KinN Therapeutics has extensive experience in selecting and developing clinically representative cancer models for preclinical evaluation.
Choosing an appropriate model for your preclinical research is vital, it can be the difference between success and failure in clinical trials. Our models are extensively characterized and we have great expertise using them for preclinical purposes.